Search by Drug Name or NDC
NDC 69339-0172-05 Ondansetron 8 mg/1 Details
Ondansetron 8 mg/1
Ondansetron is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Natco Pharma USA LLC. The primary component is ONDANSETRON HYDROCHLORIDE.
MedlinePlus Drug Summary
Ondansetron is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. Ondansetron is in a class of medications called serotonin 5-HT3 receptor antagonists. It works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting.
Related Packages: 69339-0172-05Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Ondansetron
Product Information
| NDC | 69339-0172 |
|---|---|
| Product ID | 69339-172_6d27f218-e964-4ae5-8dc7-fa8b4bda500f |
| Associated GPIs | |
| GCN Sequence Number | 016393 |
| GCN Sequence Number Description | ondansetron HCl TABLET 8 MG ORAL |
| HIC3 | H6J |
| HIC3 Description | ANTIEMETIC/ANTIVERTIGO AGENTS |
| GCN | 20042 |
| HICL Sequence Number | 006055 |
| HICL Sequence Number Description | ONDANSETRON HCL |
| Brand/Generic | Generic |
| Proprietary Name | Ondansetron |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Ondansetron |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 8 |
| Active Ingredient Units | mg/1 |
| Substance Name | ONDANSETRON HYDROCHLORIDE |
| Labeler Name | Natco Pharma USA LLC |
| Pharmaceutical Class | Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA077851 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 69339-0172-05 (69339017205)
| NDC Package Code | 69339-172-05 |
|---|---|
| Billing NDC | 69339017205 |
| Package | 500 TABLET in 1 BOTTLE (69339-172-05) |
| Marketing Start Date | 2022-10-24 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |